Clinical outcomes with neoadjuvant nivolumab (N) plus chemotherapy (C) vs C by definitive surgery in patients (pts) with resectable NSCLC: 3-y results from the phase 3 CheckMate 816 trial

JOURNAL OF CLINICAL ONCOLOGY(2023)

引用 0|浏览19
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要